<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00671541</url>
  </required_header>
  <id_info>
    <org_study_id>LCID 2006-026</org_study_id>
    <nct_id>NCT00671541</nct_id>
  </id_info>
  <brief_title>Nasospore Stent For Use in Enodscopic Sinus Surgery</brief_title>
  <official_title>Nasospore Stent For The Use in Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lahey Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lahey Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a stenting material called Nasopore. This is a
      synthetic material approved by FDA for use as a stent in postoperative sinus surgery
      patients. This study will compare the Nasopore stent to other approved stenting materials.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare other sinus stenting products to the Nasopore stent. The stents will
      be soaked in antibiotic solutions and be observed for how well they perform. Subjects will
      have a stent placed in each sinus, stents may be the standard antibiotic saturated materials
      or the new nasopore material or nasopore stent soaked in antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Principal Investigator left the institution requested study terminated.
  </why_stopped>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>This study will evaluate the efficacy of nasopore stent soaked in bacitracin in and one stent soaked in gentaymcin antibiotic solution</measure>
    <time_frame>prospective</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>Merogel stent vs. Nasopore Stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This study has two arms consiting of 50 subjects each (100 total) Arm 1 will recieve the standard stent (merogel)in their right sinus and a nasopore stent in their left sinus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bacitracin vs. gentamicin treated stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The second arm will consist of 50 new subjects. These 50 subjects will have a nasopore stent placed in the left sinus. The first 25 subjects will have nasopore stent placed postoperatively with a bacitracin soaked nasopore in right sinus the second 25 will have a gentamycin soaked nasopore stent in right sinus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Merogel Nasal Stent and Nasopore Stent</intervention_name>
    <description>Merogel Nasal Stent and Nasopore Stent</description>
    <arm_group_label>Merogel stent vs. Nasopore Stent</arm_group_label>
    <arm_group_label>bacitracin vs. gentamicin treated stent</arm_group_label>
    <other_name>Merogel Stent</other_name>
    <other_name>Nasopore Stent</other_name>
    <other_name>Bacatracin soaked stent</other_name>
    <other_name>Gentamicin soaked stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasopore Stent and either Gentamycin or Bacitracin</intervention_name>
    <description>Nasopore Stent with Bacitracin (100,000 units in 10cc(NSS)or Gentamycin(80mg in 10cc NSS)</description>
    <arm_group_label>bacitracin vs. gentamicin treated stent</arm_group_label>
    <other_name>Merogel Stent</other_name>
    <other_name>Nasopore Stent</other_name>
    <other_name>Bacatracin soaked stent</other_name>
    <other_name>Gentamicin soaked stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Evaluation by Otolaryngologist &amp; determined to need endoscopic sinus surgery

          -  Only subjects with Bilateral disease

        Exclusion Criteria:

          -  Pediatric subjects(under the age of 18)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter J. Catalano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lahey Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lahey Clinic, Inc</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2008</study_first_submitted>
  <study_first_submitted_qc>May 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2008</study_first_posted>
  <last_update_submitted>February 16, 2012</last_update_submitted>
  <last_update_submitted_qc>February 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Bacitracin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

